To address the need for rapid and sensitive quantitation of miRNA and protein biomarkers from biological samples, we have developed the FirePlex® Technology Platform. Utilizing patented FirePlex hydrogel particles and a three-region encoding design, FirePlex allows for true, in-well multiplexing, providing flexible and customizable quantification of analytes directly from biofluids, without the need for RNA isolation or sample processing prior to analysis.
In this seminar, we will highlight the unique features of the FirePlex's particle-based multiplexing, and present the FirePlex miRNA and Immunoassays which can be customized for a broad range of research areas, including organ injury, inflammation, and cancer immunology. We will also introduce the new FirePlex-HT, a two-step, no-wash immunoassay designed for high-throughput biomarker screening studies.
Learning Objectives:
1. Profiling up to 65 miRNA directly in a single sample from biofluids without RNA extraction
2. Profiling up to 70 proteins directly in a single biofluid sample
Research And Development
Animal Research
Biomarkers
Biology
Behavioral Research
Gene Expression
Biotechnology
Dna
Functional Medicine
Gene Sequencing
Biochemistry
Microfluidics
Clinical Diagnostics
Mass Cytometry
Biobank
North America67%
Asia17%
Europe17%
Website Visitors100%
Medical Laboratory Technician50%
Lab Management33%
Student17%
Academic Institution83%
Manufacturer - Other17%
